Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2025; 13(22): 105884
Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.105884
Are current scales adequate for assessing quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
Semra Demirli Atici, Aras Emre Canda, Mustafa Cem Terzi
Semra Demirli Atici, Aras Emre Canda, Mustafa Cem Terzi, Department of General Surgery, Acibadem Kent Hospital, Izmir 35620, Türkiye
Semra Demirli Atici, Aras Emre Canda, Mustafa Cem Terzi, KRC Clinic for Colorectal Surgery and Peritoneal Surface Malignancies, Izmir 35220, Türkiye
Author contributions: Demirli Atici S, Canda AE and Terzi MC wrote the manuscript; Canda AE and Terzi MC reviewed and supervised the manuscript preparation; All authors read and agreed to the published version of the manuscript.
Conflict-of-interest statement: All author(s) declare having no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Semra Demirli Atici, MD, Department of General Surgery, Acibadem Kent Hospital, 8229/1. Sk. No. 56, Izmir 35620, Türkiye. smrdemirli@hotmail.com
Received: February 10, 2025
Revised: April 5, 2025
Accepted: April 21, 2025
Published online: August 6, 2025
Processing time: 94 Days and 12.1 Hours
Core Tip

Core Tip: It is important to evaluate and improve the preoperative and postoperative quality of life (QoL) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Owing to the physical burden of surgery and the effects of chemotherapy, patients experience a significant decrease in their QoL, especially in the early stages of recovery. We believe that it would be more appropriate to evaluate QoL in a study conducted in a heterogeneous patient group, including patient-reported outcome measures with parameters that also evaluate bowel function and stoma-opening status.